Are you using or thinking of using an insulin pump to manage your diabetes? Talk with diabetics who know. Join insulin pump users with/without a sensor in a group setting to share and talk about your experiences. The group is open to children, parents, and senior citizens who are presently using a pump or are considering it. Meeting at the Library and on Zoom.
On Thursday, Nov 20, 2025, at 6:00 PM, Jennifer Angradi, Senior Territory Business Leader for Sequel Med Tech, will be the featured speaker. Jennifer brings extensive experience in diabetes technology and patient care, and she will be presenting the next era in diabetes care, the twiist™ Automated Insulin Delivery. (AID) System powered by Tidepool. Attendees will have the opportunity to learn about Sequel MedTech’s groundbreaking twiist AID System, which is transforming diabetes management. twiist is designed to simplify and personalize insulin therapy through advanced automation and real-time data integration.
Some of the many key features help people manage their type 1 diabetes with adaptive and predictive insulin delivery technology from the twiist AID System are:
· Customizable Glucose Target(s) can be set between 87-180 mg/dL, the widest correction range of any available AID system1-6, so you can stay in the range that is right for you.
· Auto Adjust powered by twiist Loop updates your 6-hour glucose prediction every 5 minutes and adjusts basal insulin all day and night to help prevent highs and lows.
· iiSure™ Technology ensures precise insulin delivery down to the microdose and detects blockages up to 9x faster than any other AID systems7, potentially reducing unexpected highs.
· The small but mighty twiist Pump weighs less than 2oz, and holds 300 units, making it the smallest available pump with such a large capacity1-6.
Jennifer will also discuss Sequel’s vision for the future of diabetes care and answer questions from attendees. The meeting is informal and encourages open discussion and sharing among participants. Mark your calendar and plan to attend this informative session